ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.18X leverage
Performance
- Low
- ₹8,820
- High
- ₹9,075
- 52 Week Low
- ₹6,313
- 52 Week High
- ₹10,691
- Open Price₹8,919
- Previous Close₹8,919
- Volume5,189
Investment Returns
- Over 1 Month + 0.06%
- Over 3 Month + 1.55%
- Over 6 Month + 1.37%
- Over 1 Year + 23.06%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 113.3
- PEG Ratio
- 0.8
- Market Cap Cr
- 22,573
- P/B Ratio
- 28.3
- Average True Range
- 210.75
- EPS
- 92.47
- Dividend Yield
- 0.4
- MACD Signal
- -24.95
- RSI
- 47.73
- MFI
- 32.23
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹9,029.00
+
110.5
(1.24%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹9,063.80
- 50 Day
- ₹9,093.97
- 100 Day
- ₹9,027.15
- 200 Day
- ₹8,692.90
Resistance and Support
8974.67
- R3 9,384.33
- R2 9,229.67
- R1 9,129.33
- S1 8,874.33
- S2 8,719.67
- S3 8,619.33
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹9,029 As on 31 December, 2025 | 20:13
The Market Cap of AstraZeneca Pharma India is ₹22572.5 Cr As on 31 December, 2025 | 20:13
The P/E ratio of AstraZeneca Pharma India is 113.3 As on 31 December, 2025 | 20:13
The PB ratio of AstraZeneca Pharma India is 28.3 As on 31 December, 2025 | 20:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.